Tamarack Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Tamarack Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-850,000	Closed	-$10.6M	–	38
2016 Q4	$10.6M	Sell	850,000 -1,000,000	-54%	-$12M	7.48%	1
2016 Q3	$24.7M	Sell	1,850,000 -250,000	-12%	-$2.51M	7.76%	4
2016 Q2	$15.5M	Buy	2,100,000 +500,000	+31%	+$3.75M	5.95%	4
2016 Q1	$10.2M	Buy	+1,600,000	New	+$8.97M	3.58%	13

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Tamarack Advisers's ARIA Position: Q1 2017 in Review

Tamarack Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 850,000 shares — an estimated $10.6M sold.

Tamarack Advisers first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $24.7M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Tamarack Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Tamarack Advisers sold 850,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $10.6M.
Tamarack Advisers first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Tamarack Advisers's Ariad Pharmaceuticals Inc position peaked at $24.7M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Tamarack Advisers's 13F filing for Q1 2017, filed 12 May 2017.